Transcatheter aortic valve implantation (TAVI) has risen over the past 20 years as a safe and
effective alternative to surgical aortic valve replacement for treatment of severe aortic …

Transcatheter aortic valve replacement (TAVR) has developed into an established therapy
for patients with severe aortic stenosis (AS) across the spectrum of surgical risk. Despite …

Background Randomised trial data assessing the safety and efficacy of the self-expanding
intra-annular Portico transcatheter aortic valve system (Abbott Structural Heart, St Paul, MN …

Background Transcatheter aortic valve implantation (TAVI) has become standard treatment
for elderly patients with symptomatic severe aortic valve stenosis. The ACURATE neo AS …

A total of 1001 subjects (82.0 years, 62.5% female, 63.7% NYHA III/IV at baseline) with
severe aortic stenosis at high surgical risk were enrolled in the prospective CONFIDENCE …

Transcatheter aortic valve replacement (TAVR) is an established treatment for patients with
symptomatic severe aortic stenosis. In recent years, an emphasis has been placed on …

Objective At our institution, we actively perform aortic valve neocuspidization (AVNeo) for
aortic valve stenosis (AS) with a small annulus. In this report, we aimed to evaluate the …

Background The self-expanding, intra-annular Navitor (Abbott Structural Heart) valve
includes an outer cuff to reduce paravalvular leak (PVL) and large stent cells for future …

Introduction Currently, several balloon-expandable (BE) and self-expanding (SE)
transcatheter aortic valves (TAVs) are available in clinical practice. Each of them has …

Background No study has evaluated the impact of the additional manipulation demanded by
multiple resheathing (MR) in patients undergoing transcatheter aortic valve replacement …